# Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

> **NCT00614731** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 25 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** KLH carrier-protein

## Key facts

- **NCT ID:** NCT00614731
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614731, "Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00614731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*